Kummen, M., Vesterhus, M., Trøseid, M., Moum, B., Svardal, A., Boberg, K. M., . . . Hov, J. R. (2016). Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function. United European Gastroenterol J.
Čikaški stil citiranjaKummen, Martin, et al. "Elevated Trimethylamine-N-oxide (TMAO) Is Associated With Poor Prognosis in Primary Sclerosing Cholangitis Patients With Normal Liver Function." United European Gastroenterol J 2016.
MLA način citiranjaKummen, Martin, et al. "Elevated Trimethylamine-N-oxide (TMAO) Is Associated With Poor Prognosis in Primary Sclerosing Cholangitis Patients With Normal Liver Function." United European Gastroenterol J 2016.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.